[go: up one dir, main page]

DK3157510T3 - Antimikrobielle sammensætninger med brusemidler - Google Patents

Antimikrobielle sammensætninger med brusemidler Download PDF

Info

Publication number
DK3157510T3
DK3157510T3 DK15810507.2T DK15810507T DK3157510T3 DK 3157510 T3 DK3157510 T3 DK 3157510T3 DK 15810507 T DK15810507 T DK 15810507T DK 3157510 T3 DK3157510 T3 DK 3157510T3
Authority
DK
Denmark
Prior art keywords
antimicrobial compositions
effervescent agents
effervescent
agents
antimicrobial
Prior art date
Application number
DK15810507.2T
Other languages
English (en)
Inventor
Danping Li
Original Assignee
Melinta Subsidiary Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3157510(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Subsidiary Corp filed Critical Melinta Subsidiary Corp
Application granted granted Critical
Publication of DK3157510T3 publication Critical patent/DK3157510T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK15810507.2T 2014-06-20 2015-06-19 Antimikrobielle sammensætninger med brusemidler DK3157510T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014786P 2014-06-20 2014-06-20
PCT/US2015/036605 WO2015196027A1 (en) 2014-06-20 2015-06-19 Antimicrobial compositions with effervescent agents

Publications (1)

Publication Number Publication Date
DK3157510T3 true DK3157510T3 (da) 2019-07-01

Family

ID=54868661

Family Applications (2)

Application Number Title Priority Date Filing Date
DK15810507.2T DK3157510T3 (da) 2014-06-20 2015-06-19 Antimikrobielle sammensætninger med brusemidler
DK19165084.5T DK3581180T3 (da) 2014-06-20 2015-06-19 Antimikrobielle sammensætninger med brusemidler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19165084.5T DK3581180T3 (da) 2014-06-20 2015-06-19 Antimikrobielle sammensætninger med brusemidler

Country Status (32)

Country Link
US (2) US20150366857A1 (da)
EP (3) EP3919057A1 (da)
JP (2) JP6995479B2 (da)
CN (2) CN106572982B9 (da)
AR (1) AR100920A1 (da)
AU (3) AU2015276954B2 (da)
BR (1) BR112016029761B1 (da)
CA (1) CA2952950C (da)
CL (2) CL2016003273A1 (da)
CR (2) CR20200565A (da)
CY (2) CY1121995T1 (da)
DK (2) DK3157510T3 (da)
EA (1) EA034152B1 (da)
EC (1) ECSP16095540A (da)
ES (2) ES2732865T3 (da)
HR (2) HRP20211685T1 (da)
HU (2) HUE044764T2 (da)
IL (1) IL249622A0 (da)
LT (2) LT3157510T (da)
MX (2) MX368940B (da)
PE (2) PE20210927A1 (da)
PH (2) PH12016502548B1 (da)
PL (2) PL3157510T3 (da)
PT (2) PT3157510T (da)
RS (2) RS62538B1 (da)
SI (2) SI3157510T1 (da)
SM (2) SMT202100618T1 (da)
SV (1) SV2016005349A (da)
TR (1) TR201909417T4 (da)
TW (2) TWI732337B (da)
UY (1) UY36184A (da)
WO (1) WO2015196027A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022240897A1 (en) * 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194617A (en) * 1988-12-17 1993-03-16 Meiji Seika Kaisha, Ltd. 2,3-disubstituted-4-hydroxyquinoline derivatives
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
WO1997011068A1 (fr) 1995-09-22 1997-03-27 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridone-carboxylique ou leurs sels et agent antibacterien les contenant comme ingredient actif
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
UA73287C2 (en) 1998-09-14 2005-07-15 Ranbaxy Lab Ltd Ciprofloxacin formulation with delayed release
US6187317B1 (en) * 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
MX2007001134A (es) 2004-07-30 2007-04-17 Abbott Lab Preparacion de antibacterianos de acido piridonacarboxilico.
DK3056492T3 (da) * 2004-10-08 2021-12-13 Abbvie Inc Megluminsalt og krystallinke former deraf af et lægemiddel (delafloxacin)
BRPI0517891A (pt) * 2004-11-24 2008-10-21 Medpointe Healthcare Inc composições compreendendo azelastina e métodos de uso das mesmas
RS52354B (en) 2005-04-11 2012-12-31 Abbott Laboratories PHARMACEUTICAL MIXTURES WHICH HAVE ADVANCED DISSOLUTION PROFILES FOR Slightly Soluble Medicines
DE602005007205D1 (de) 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
US7611739B2 (en) 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US7736485B2 (en) * 2006-08-11 2010-06-15 Aqua Resources Corporation Nanoplatelet magnesium hydroxides and methods of preparing same
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
NZ578204A (en) 2006-12-22 2012-05-25 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
AU2008258596B2 (en) * 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
EA025637B1 (ru) * 2008-11-15 2017-01-30 Мелинта Терапьютикс, Инк. Противомикробные композиции
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
GB201020076D0 (en) * 2010-11-26 2011-01-12 Liverpool School Tropical Medicine Antimalarial compounds
EP3581574A1 (en) * 2011-01-10 2019-12-18 Infinity Pharmaceuticals, Inc. A composition for oral administration for use in the treatment of cancer, an inflammatory disease or an auto-immune disease
KR101900249B1 (ko) * 2011-01-14 2018-11-02 스페로 트리넴, 인코포레이티드 자이라제 억제제 (r)­1­에틸­3­[6­플루오로­5­[2­(1­하이드록시­1­메틸­에틸)피리미딘­5­일]­7­(테트라하이드로푸란­2­일)­1h­벤즈이미다졸­2­일]우레아의 고체 형태
JP2013034468A (ja) * 2011-08-10 2013-02-21 Nisshin Sugar Mfg Co Ltd 発泡成型甘味料
US20140328884A1 (en) * 2011-12-16 2014-11-06 Celanese Eva Performance Polymers, Inc. Controlled release vehicles having desired void volume architectures
CN102697751A (zh) * 2012-05-30 2012-10-03 河南牧翔动物药业有限公司 一种畜禽专用恩诺沙星泡腾分散片及其制备方法

Also Published As

Publication number Publication date
AU2021286284B2 (en) 2024-02-29
HUE056298T2 (hu) 2022-02-28
HRP20191133T1 (hr) 2019-09-20
CA2952950A1 (en) 2015-12-23
TR201909417T4 (tr) 2019-07-22
PL3157510T3 (pl) 2019-12-31
BR112016029761A8 (pt) 2021-06-29
NZ727638A (en) 2023-08-25
CR20160592A (es) 2017-02-21
AU2015276954A1 (en) 2017-01-12
PH12016502548A1 (en) 2017-04-10
AU2020256457B2 (en) 2021-09-30
AR100920A1 (es) 2016-11-09
SMT201900348T1 (it) 2019-09-09
TWI705814B (zh) 2020-10-01
HUE044764T2 (hu) 2019-11-28
CA2952950C (en) 2023-11-14
CY1125395T1 (el) 2023-03-24
DK3581180T3 (da) 2021-11-08
TW201625249A (zh) 2016-07-16
CL2020003153A1 (es) 2021-06-25
CL2016003273A1 (es) 2017-08-04
ES2897576T3 (es) 2022-03-01
PH12022550979A1 (en) 2023-06-26
HRP20211685T1 (hr) 2022-02-04
CY1121995T1 (el) 2020-10-14
AU2021286284A1 (en) 2022-01-06
EA201692532A1 (ru) 2017-05-31
RS62538B1 (sr) 2021-12-31
ECSP16095540A (es) 2017-03-31
CN114831955B (zh) 2024-03-12
BR112016029761A2 (pt) 2017-08-22
EA034152B1 (ru) 2020-01-09
TWI732337B (zh) 2021-07-01
CN106572982B9 (zh) 2022-07-08
CN106572982A (zh) 2017-04-19
WO2015196027A1 (en) 2015-12-23
JP7149991B2 (ja) 2022-10-07
MX2019012608A (es) 2019-12-02
BR112016029761B1 (pt) 2023-03-07
MX368940B (es) 2019-10-21
CN106572982B (zh) 2022-06-03
SV2016005349A (es) 2017-08-31
US20200237744A1 (en) 2020-07-30
US20150366857A1 (en) 2015-12-24
PE20210927A1 (es) 2021-05-19
MX2016017350A (es) 2017-04-06
PH12016502548B1 (en) 2023-05-24
EP3581180B1 (en) 2021-08-04
EP3157510A4 (en) 2018-02-21
ES2732865T3 (es) 2019-11-26
SI3157510T1 (sl) 2019-09-30
LT3157510T (lt) 2019-09-25
EP3157510A1 (en) 2017-04-26
SMT202100618T1 (it) 2022-01-10
CN114831955A (zh) 2022-08-02
LT3581180T (lt) 2021-12-27
TW202005650A (zh) 2020-02-01
EP3919057A1 (en) 2021-12-08
JP6995479B2 (ja) 2022-01-14
PE20170304A1 (es) 2017-04-19
EP3581180A1 (en) 2019-12-18
PT3581180T (pt) 2021-11-09
AU2020256457A1 (en) 2020-11-12
PT3157510T (pt) 2019-06-21
PL3581180T3 (pl) 2022-02-07
IL249622A0 (en) 2017-02-28
EP3157510B1 (en) 2019-03-27
JP2020183415A (ja) 2020-11-12
CR20200565A (es) 2021-01-14
AU2015276954B2 (en) 2020-07-23
UY36184A (es) 2016-01-29
JP2017518349A (ja) 2017-07-06
RS59064B1 (sr) 2019-08-30
SI3581180T1 (sl) 2021-12-31

Similar Documents

Publication Publication Date Title
HK1251922A1 (zh) 抗微生物組合物及其用途
PL3236978T3 (pl) Kompozycja przeciwdrobnoustrojowa
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3542812T3 (da) Glycopeptidsammensætninger
BR112016023341A2 (pt) composição desinfetante de ação rápida
BR112017001922A2 (pt) composições fungicidas
EP3415008A4 (en) GERMIC COMPOSITION
FR3024363B1 (fr) Composition thermogelifiable
PT3261437T (pt) Compostos e composições fungicidas
EP3443078A4 (en) ANTIMICROBIAL COMPOSITIONS
CL2017000639A1 (es) Composición
DK3451829T3 (da) Antimikrobielle sammensætninger
BR112016018442A2 (pt) agentes antibacterianos
FR3020948B1 (fr) Composition antimicrobienne
EP3236746C0 (en) COMPOSITION
DK3200827T3 (da) Sammensætninger
DK3217964T3 (da) Sammensætning
FR3025106B1 (fr) Composition antimicrobienne
FR3019552B1 (fr) Composition filmogene
EP3405218A4 (en) DISINFECTING COMPOSITION
DK3174396T3 (da) Synergistisk antimikrobiel sammensætning
DK3157510T3 (da) Antimikrobielle sammensætninger med brusemidler
MA40840A (fr) Composition herbicide
EP3509419C0 (en) ANTIMICROBIAL COMPOSITION
UA28385S (uk) Пластир бактерицидний